DINSMORE CAPITAL MANAGEMENT CO/NJ - MERRIMACK PHARMACEUTICALS IN ownership

Quarter-by-quarter ownership
DINSMORE CAPITAL MANAGEMENT CO/NJ ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2014$956,000
+26.6%
500,0000.0%0.37%
+25.9%
Q3 2014$755,000
+13.7%
500,0000.0%0.30%
+16.5%
Q2 2014$664,000
+30.7%
500,0000.0%0.26%
+26.9%
Q1 2014$508,000
-51.1%
500,000
-50.0%
0.20%
-52.3%
Q4 2013$1,038,000
+14.1%
1,000,0000.0%0.42%
+10.8%
Q3 2013$910,0001,000,0000.38%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 16,490,000$25,947,00012.49%
SILVERBACK ASSET MANAGEMENT LLC 14,500,000$22,711,0002.37%
TANG CAPITAL MANAGEMENT LLC 3,500,000$5,259,0001.94%
ARISTEIA CAPITAL, L.L.C. 11,932,000$18,727,0000.95%
WOLVERINE ASSET MANAGEMENT LLC 12,600,000$19,576,0000.46%
Polar Capital LLP 3,120,000$4,965,0000.10%
Tekla Capital Management LLC 1,485,000$2,336,0000.08%
MIZUHO SECURITIES USA LLC 194,000$305,0000.08%
PALISADE CAPITAL MANAGEMENT, LP 1,410,000$2,206,0000.06%
LAZARD ASSET MANAGEMENT LLC 11,010,000$17,375,0000.04%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders